Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thrombosis formation refers to the process by which a blood clot (thrombus) forms within a blood vessel, obstructing blood flow. It is a complex, multi-step cascade involving endothelial damage, activation of platelets, the coagulation cascade, and the formation of fibrin to stabilize the clot. Key players include tissue factor, thrombin, and platelets. Thrombosis is central to a variety of acute and chronic cardiovascular pathologies, such as myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism. Therapeutic interventions (e.g., anticoagulants, antiplatelet agents) target specific steps or participants in the thrombotic process, not “thrombosis formation” as a single discrete target. Therefore, thrombosis formation should not be listed as a canonical molecular target, and any queries about it should be redirected towards specific molecules or pathways (such as "Factor Xa," "Tissue factor," or "Platelet P2Y12 receptor")[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombosis formation.